Bipolar disorder and <i>myo</i>‐inositol: a review of the magnetic resonance spectroscopy findings

Bipolar Disorders - Tập 7 Số 1 - Trang 1-10 - 2005
Peter H. Silverstone1, Brent M McGrath1, Hyeon-Jin Kim2
1Departments of Psychiatry
2Biomedical Engineering, University of Alberta, Edmonton, Alberta, Canada

Tóm tắt

Objectives:  Myo‐inositol is an important component of the phosphatidylinositol second messenger system (PI‐cycle). Alterations in PI‐cycle activity have been suggested to be involved in the pathophysiology and/or treatment of bipolar disorder. More specifically, lithium has been suggested to act primarily by lowering myo‐inositol concentrations, the so‐called inositol‐depletion hypothesis. myo‐Inositol concentrations can be measured in vivo with magnetic resonance spectroscopy (MRS).Methods:  The current review primarily examines animal and human MRS studies that evaluated the role of myo‐inositol in bipolar illness and treatment.Results:  Studies have been carried out in patients who are manic, depressed, and euthymic, both on and off treatment. However, there are several limitations of these studies.Conclusions:  The preclinical and clinical MRS findings were generally supportive of the involvement of myo‐inositol in bipolar disorder and its treatment. Overall, in bipolar patients who are manic or depressed there are abnormalities in brain myo‐inositol concentrations, with changes in frontal and temporal lobes, as well as the cingulate gyrus and basal ganglia. These abnormalities are not seen in either euthymic patients or healthy controls, possibly due to a normalizing effect of treatment with either lithium or sodium valproate. There is also increasing evidence that sodium valproate may also act upon the PI‐cycle. Nonetheless, it remains uncertain if these changes in myo‐inositol concentration are primary or secondary. Findings regarding the specific inositol‐depletion hypothesis are also generally supportive in acutely ill patients, although it is not yet possible to definitively confirm or refute this hypothesis based on the current MRS evidence.

Từ khóa


Tài liệu tham khảo

10.1176/appi.ajp.161.2.217

10.1034/j.1399-5618.2003.00031.x

10.4088/JCP.v65n0405

10.1016/j.euroneuro.2004.03.003

10.1176/appi.ajp.160.7.1263

Ulrich ML, 2003, Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels, J Psychiatry Neurosci, 28, 115

10.1017/S1461145703003717

10.1038/sj.npp.1300400

Wanaverbecq N, 2003, The plasma membrane calcium‐ATPase as a major mechanism for intracellular calcium regulation in neurons from the rat superior cervical ganglion, J Physiol, 550, 83, 10.1113/jphysiol.2002.035782

Welsby PJ, 2003, A mechanism for the direct regulation of T‐type calcium channels by Ca2+/Calmodulin‐dependent kinase II, J Neurosci, 23, 10116, 10.1523/JNEUROSCI.23-31-10116.2003

10.1073/pnas.0308188100

Brandao LA, 2004, MR Spectroscopy of the Brain

Moore GJ, 2002, Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders, Psychopharmacol Bull, 36, 5

10.1046/j.1440-1614.2002.00992.x

10.1111/j.1471-4159.1992.tb09273.x

Atack JR., 2000, Bipolar Medications – Mechanisms of Action, 1

10.1016/0167-4889(93)90121-5

10.1038/newbio233267a0

10.1016/0006-291X(76)90839-1

10.1042/bj2060587

10.1038/341197a0

10.1016/0092-8674(89)90026-3

10.1016/0006-3223(86)90133-2

Preece NE, Society of Magnetic Resonance in Medicine, 428

Preece NE, 1992, Lithium‐induced modulation of cerebral inositol phosphate metabolism in the rat: a multinuclear magnetic resonance study in vivo, Lithium, 3, 287

10.1016/S0006-8993(00)02797-9

10.1159/000117967

10.1016/S0079-6565(99)00004-7

10.1017/S0033291799008442

10.1017/S003329170003347X

10.1016/S0925-4927(00)00083-4

10.1016/S0022-3956(98)00033-8

Moore GJ, 1999, Temporal dissociation between lithium‐induced changes in frontal lobe myo‐inositol and clinical response in manic‐depressive illness, Am J Psychiatry, 156, 1902, 10.1176/ajp.156.12.1902

10.1034/j.1399-5618.2000.20302.x

10.1016/0165-0327(92)90099-R

10.1016/0165-0327(94)90116-3

10.1007/s004060050052

10.1176/ajp.154.1.116

10.1016/S0006-3223(99)00159-6

10.1097/01.rli.0000073446.43445.20

10.1016/S0893-133X(00)00207-4

10.1176/appi.ajp.160.8.1442

10.1016/0920-9964(92)90059-E

10.1016/0165-0327(91)90064-Y

10.1016/0165-0327(93)90097-4

10.1034/j.1399-5618.2002.02235.x

10.1016/S0006-3223(99)00183-3

10.1176/ajp.152.6.915

10.1016/0165-0327(94)00089-R

10.1007/s004060050054

Bruhn H, Society of Magnetic Resonance in Medicine, 1543

10.1016/0925-4927(94)90010-8

10.1017/S0033291799001439

10.1111/j.1440-1819.2004.01197.x

10.1002/hup.420

10.1016/S0006-3223(02)01744-4

10.1016/0006-3223(95)00382-7

10.1016/S0006-3223(99)00076-1

10.1016/S0006-3223(01)01069-1

10.1038/sj.npp.1300520

10.1017/S0033291700009132

10.1176/ajp.154.8.1148

10.1111/j.1471-4159.1981.tb00590.x

10.1002/hup.434

10.1002/syn.10275

Vadnal R, 1995, Myo‐inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate, Neuropsychopharmacology, 12, 277, 10.1016/0893-133X(94)00088-H

10.1016/S0006-8993(99)02371-9

10.1074/jbc.M004179200

10.1016/0091-3057(93)90360-6

10.1046/j.1365-2958.2003.03641.x

10.1073/pnas.94.9.4757

10.1046/j.1365-2958.2000.01886.x

10.1038/417292a

Thông tin
Thông tin xuất bản

Bipolar Disorders

Tập 7 Số 1

1-10

Thông tin tác giả